-
1
-
-
0032601052
-
Descriptive epidemiology of primary brain and CNS tumors: Results from the central brain tumor registry of the United States, 1990-1994
-
Surawicz, T. S., McCarthy, B. J., Kupelian, V., et al. Descriptive epidemiology of primary brain and CNS tumors: results from the central brain tumor registry of the United States, 1990-1994. Neuro Oncol 1, 14-25 (1999). DOI: 10.1215/15228517-1-1-14
-
(1999)
Neuro Oncol
, vol.1
, pp. 14-25
-
-
Surawicz, T.S.1
McCarthy, B.J.2
Kupelian, V.3
-
2
-
-
48249125791
-
Malignant gliomas in adults
-
Wen, P. Y., Kesari, S. Malignant gliomas in adults. N Engl J Med 492-507 (2008). DOI: 10.1056/NEJMra0708126
-
(2008)
N Engl J Med
, pp. 492-507
-
-
Wen, P.Y.1
Kesari, S.2
-
3
-
-
77952555038
-
Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma
-
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60, 166-193 (2010). DOI: 10.3322/caac.20069
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 166-193
-
-
van Meir, E.G.1
Hadjipanayis, C.G.2
Norden, A.D.3
-
4
-
-
35949002429
-
Malignant astrocytic glioma: Genetics, biology, and paths to treatment
-
Furnari, F. B., Fenton, T., Bachoo, R. M., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-2710 (2007). DOI: 10.1101/gad.1596707
-
(2007)
Genes Dev
, vol.21
, pp. 2683-2710
-
-
Furnari, F.B.1
Fenton, T.2
Bachoo, R.M.3
-
5
-
-
32944469010
-
European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group: Changing paradigms-an update on the multidisciplinary management of malignant glioma
-
Stupp, R., Hegi, M. E., van den Bent, M. J., et al. European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group: changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 11, 165-180 (2006). PMID: 16476837
-
(2006)
Oncologist
, vol.11
, pp. 165-180
-
-
Stupp, R.1
Hegi, M.E.2
van den Bent, M.J.3
-
6
-
-
35348964557
-
Advances in radiation therapy for brain tumors
-
Stieber, V. W., Mehta, M. P. Advances in radiation therapy for brain tumors. Neurol Clin 25, 1005-1033 (2007). DOI: 10.1016/ j.ncl.2007.07.005
-
(2007)
Neurol Clin
, vol.25
, pp. 1005-1033
-
-
Stieber, V.W.1
Mehta, M.P.2
-
7
-
-
0028234529
-
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
-
Darnell, J. E. Jr, Kerr, I. M., Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994). DOI: 10.1126/ science.8197455
-
(1994)
Science
, vol.264
, pp. 1415-1421
-
-
Darnell, J.E.1
Kerr, I.M.2
Stark, G.R.3
-
8
-
-
0030840464
-
STATs and Gene regulation
-
Darnell, J. E. Jr. STATs and Gene regulation. Science 277, 1630- 1635 (1997). DOI: 10.1126/science.277.5332.1630
-
(1997)
Science
, vol.277
, pp. 1630-1635
-
-
Darnell, J.E.1
-
9
-
-
33847351136
-
The JAK-STAT signaling pathway: Input and output integration
-
Murray, P. J. The JAK-STAT signaling pathway: input and output integration. J Immunol 178, 2623-2629 (2007). PMID: 17312100
-
(2007)
J Immunol
, vol.178
, pp. 2623-2629
-
-
Murray, P.J.1
-
10
-
-
0028921573
-
Jaks and Stats in signaling by the cytokine receptor superfamily
-
Ihle, J., Kerr, I. M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11, 69-74 (1995). DOI: 10.1016/ S0168-9525(00)89000-9
-
(1995)
Trends Genet
, vol.11
, pp. 69-74
-
-
Ihle, J.1
Kerr, I.M.2
-
11
-
-
69149098253
-
Signal transducer and activator of transcription-3, inflammation, and cancer: How intimate is the relationship?
-
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171, 59-76 (2009). DIO: 10.1111/j.1749-6632.2009.04911.x
-
(2009)
Ann N Y Acad Sci
, vol.1171
, pp. 59-76
-
-
Aggarwal, B.B.1
Kunnumakkara, A.B.2
Harikumar, K.B.3
-
12
-
-
40949124676
-
Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes
-
Seethala, R. R., Gooding, W. E., Handler, P. N., et al. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. Clin Cancer Res 14, 1303-1309 (2008). DOI: 10.1158/1078- 0432.CCR-07-1543
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1303-1309
-
-
Seethala, R.R.1
Gooding, W.E.2
Handler, P.N.3
-
13
-
-
0036554816
-
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
-
Buettner, R., Mora, L. B., Jove, R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8, 945-954 (2002). PMID: 11948098
-
(2002)
Clin Cancer Res
, vol.8
, pp. 945-954
-
-
Buettner, R.1
Mora, L.B.2
Jove, R.3
-
14
-
-
0032984589
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
-
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115 (1999). DOI: 10.1016/S1074-7613(00)80011-4
-
(1999)
Immunity
, vol.10
, pp. 105-115
-
-
Catlett-Falcone, R.1
Landowski, T.H.2
Oshiro, M.M.3
-
15
-
-
0035136846
-
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
-
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107, 351-362 (2001). DOI: 10.1172/JCI9940
-
(2001)
J Clin Invest
, vol.107
, pp. 351-362
-
-
Epling-Burnette, P.K.1
Liu, J.H.2
Catlett-Falcone, R.3
-
16
-
-
3042515162
-
IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells
-
Barton, B. E., Murphy, T. F., Adem, P., et al. IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells. BMC Cancer 1, 19 (2001). PMID: 11710966
-
(2001)
BMC Cancer
, vol.1
, pp. 19
-
-
Barton, B.E.1
Murphy, T.F.2
Adem, P.3
-
17
-
-
0031962229
-
Cancer patients use of nonproven therapy: A 5-year follow-up study
-
Risberg, T., Lund, E., Wist, E., et al. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol 16, 6-12 (1998). PMID: 9440716
-
(1998)
J Clin Oncol
, vol.16
, pp. 6-12
-
-
Risberg, T.1
Lund, E.2
Wist, E.3
-
18
-
-
3042576191
-
Complementary and alternative medicine use among adults: United States, 2002
-
Barnes, P. M., Powell-Griner, E., McFann, K., et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343, 1-19 (2004). DOI: 10.1016/j.sigm.2004.07.003
-
(2004)
Adv Data
, vol.343
, pp. 1-19
-
-
Barnes, P.M.1
Powell-Griner, E.2
McFann, K.3
-
19
-
-
0032508952
-
Trends in alternative medicine use in the united states, 1990-1997: Results of a follow-up national survey
-
Eisenberg, D. M., Davis, R. B., Ettner, S. L., et al. Trends in alternative medicine use in the united states, 1990-1997: results of a follow-up national survey. JAMA 280, 1569-1575 (1998) DOI: 10.1001/ jama.280.18.1569
-
(1998)
JAMA
, vol.280
, pp. 1569-1575
-
-
Eisenberg, D.M.1
Davis, R.B.2
Ettner, S.L.3
-
20
-
-
4344601194
-
The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia
-
Gerber, G. S., Fitzpatrick, J. M. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int 94, 338-344 (2004). DOI: 10.1111/j.1464-410X.2004.04962.x
-
(2004)
BJU Int
, vol.94
, pp. 338-344
-
-
Gerber, G.S.1
Fitzpatrick, J.M.2
-
21
-
-
68349110517
-
Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling
-
Che, Y., Hou, S., Kang, Z., Lin, Q. Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling. Oncol Rep 22, 377-383 (2009). DOI: 10.3892/or_00000448
-
(2009)
Oncol Rep
, vol.22
, pp. 377-383
-
-
Che, Y.1
Hou, S.2
Kang, Z.3
Lin, Q.4
-
22
-
-
64249124059
-
Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells
-
Baron, A., Mancini, M., Caldwell, E., et al. Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells. BJU Int 103, 1275-1283 (2009). DOI: 10.1111/j.1464-410X.2008.08266.x
-
(2009)
BJU Int
, vol.103
, pp. 1275-1283
-
-
Baron, A.1
Mancini, M.2
Caldwell, E.3
-
23
-
-
38449120751
-
Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling
-
Yang, Y., Ikezoe, T., Zheng, Z., et al. Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling. Int J Oncol 31, 593-600 (2007). PMID: 17671686
-
(2007)
Int J Oncol
, vol.31
, pp. 593-600
-
-
Yang, Y.1
Ikezoe, T.2
Zheng, Z.3
-
24
-
-
0035313644
-
Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apoptosis and necrosis in human prostatic LNCaP cells
-
Iguchi, K., Okumura, N., Usui, S., et al. Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apoptosis and necrosis in human prostatic LNCaP cells. Prostate 47, 59-65 (2001). DOI: 10.1002/pros.1047.abs
-
(2001)
Prostate
, vol.47
, pp. 59-65
-
-
Iguchi, K.1
Okumura, N.2
Usui, S.3
-
25
-
-
10344251011
-
Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines
-
Ravenna, L., Di Silverio, F., Russo, M. A., et al. Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines. Prostate 29, 219-230 (1996). DOI: 10.1002/ (SICI)1097-0045(199610)29:4<219::AID-PROS3>3.3.CO;2-S
-
(1996)
Prostate
, vol.29
, pp. 219-230
-
-
Ravenna, L.1
Di Silverio, F.2
Russo, M.A.3
-
26
-
-
60849105972
-
Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization
-
Petrangeli, E., Lenti, L., Buchetti, B., et al. Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization. J Cell Physiol 219, 69-76 (2009). DOI: 10.1002/jcp.21648
-
(2009)
J Cell Physiol
, vol.219
, pp. 69-76
-
-
Petrangeli, E.1
Lenti, L.2
Buchetti, B.3
-
27
-
-
33750332521
-
ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib
-
Yang, Y., Ikezoe, T., Nishioka, C., et al. ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. Cancer Sci 97, 1404-1409 (2006). DOI: 10.1111/j.1349-7006.2006.00325.x
-
(2006)
Cancer Sci
, vol.97
, pp. 1404-1409
-
-
Yang, Y.1
Ikezoe, T.2
Nishioka, C.3
-
28
-
-
1642486367
-
Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling
-
Yang, Y., Ikezoe, T., Saito, T., et al. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling. Cancer Sci 95, 176-180 (2004). DOI: 10.1111/j.1349-7006.2004.tb03200.x
-
(2004)
Cancer Sci
, vol.95
, pp. 176-180
-
-
Yang, Y.1
Ikezoe, T.2
Saito, T.3
-
29
-
-
80052226056
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review
-
Komotar, R. J., Otten, M. L., Moise, G., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review. Clin Med Oncol 2, 421-422 (2008). PMID: 21892310
-
(2008)
Clin Med Oncol
, vol.2
, pp. 421-422
-
-
Komotar, R.J.1
Otten, M.L.2
Moise, G.3
-
30
-
-
20044366163
-
European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp, R., Mason, W. P., van den Bent, M. J., et al. European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group: radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-996 (2005). PMID: 15758009
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
-
31
-
-
18244390977
-
The antitumor effects of angelica sinensis on malignant brain tumors in vitro and in vivo
-
Tsai, N. M., Lin, S. Z., Lee, C. C., et al. The antitumor effects of angelica sinensis on malignant brain tumors in vitro and in vivo. Clin Cancer Res 11, 3475-3484 (2005). DOI: 10.1158/1078-0432.CCR-04-1827
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3475-3484
-
-
Tsai, N.M.1
Lin, S.Z.2
Lee, C.C.3
-
32
-
-
49749119221
-
Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme
-
Yin, D., Wakimoto, N., Xing, H., et al. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer 123, 1364-1375 (2008). DOI: 10.1002/ ijc.23648
-
(2008)
Int J Cancer
, vol.123
, pp. 1364-1375
-
-
Yin, D.1
Wakimoto, N.2
Xing, H.3
-
33
-
-
78651298431
-
Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling
-
Parajuli, P., Joshee, N., Chinni, S. R., et al. Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling. J Neurooncol 101, 15-24 (2011). DOI: 10.1007/ s11060-010-0221-x
-
(2011)
J Neurooncol
, vol.101
, pp. 15-24
-
-
Parajuli, P.1
Joshee, N.2
Chinni, S.R.3
-
34
-
-
34247131445
-
Evaluation of cell death caused by an ethanolic extract of serenoae repentis fructus (Prostasan®) on human carcinoma cell lines
-
Hostanska, K., Suter, A., Melzer, J., et al. Evaluation of cell death caused by an ethanolic extract of serenoae repentis fructus (Prostasan®) on human carcinoma cell lines. Anticancer Res 27, 873-881 (2007). PMID: 17465214
-
(2007)
Anticancer Res
, vol.27
, pp. 873-881
-
-
Hostanska, K.1
Suter, A.2
Melzer, J.3
-
35
-
-
58149340584
-
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas
-
Abou-Ghazal, M., Yang, D. S., Qiao, W., et al. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res 14, 8228-8235 (2008). DOI: 10.1158/1078-0432.CCR- 08-1329
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8228-8235
-
-
Abou-Ghazal, M.1
Yang, D.S.2
Qiao, W.3
-
36
-
-
84867504682
-
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
-
Doucette, T. A., Kong, L. Y., Yang, Y., et al. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol 14, 1136-1145 (2012). DOI: 10.1093/neuonc/nos139
-
(2012)
Neuro Oncol
, vol.14
, pp. 1136-1145
-
-
Doucette, T.A.1
Kong, L.Y.2
Yang, Y.3
-
37
-
-
75149195336
-
The transcriptional network for mesenchymal transformation of brain tumours
-
Carro, M. S., Lim, W. K., Alvarez, M. J., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325 (2010). DOI: 10.1038/nature08712
-
(2010)
Nature
, vol.463
, pp. 318-325
-
-
Carro, M.S.1
Lim, W.K.2
Alvarez, M.J.3
-
38
-
-
51049123447
-
Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas
-
Brantley, E. C., Benveniste, E. N. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6, 675-684 (2008). DOI: 10.1158/1541-7786. MCR-07-2180
-
(2008)
Mol Cancer Res
, vol.6
, pp. 675-684
-
-
Brantley, E.C.1
Benveniste, E.N.2
-
39
-
-
70849122697
-
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations
-
Brennan, C., Momota, H., Hambardzumyan, D., et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4, e7752 (2009). DOI: 10.1371/journal.pone.0007752
-
(2009)
Plos One
, pp. 4
-
-
Brennan, C.1
Momota, H.2
Hambardzumyan, D.3
-
40
-
-
0037028249
-
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells
-
Rahaman, S. O., Harbor, P. C., Chernova, O., et al. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21, 8404-8413 (2002). DOI: 10.1038/sj.onc.1206047
-
(2002)
Oncogene
, vol.21
, pp. 8404-8413
-
-
Rahaman, S.O.1
Harbor, P.C.2
Chernova, O.3
|